140 related articles for article (PubMed ID: 25652399)
1. Mitochondrial complex I deficiency leads to inflammation and retinal ganglion cell death in the Ndufs4 mouse.
Yu AK; Song L; Murray KD; van der List D; Sun C; Shen Y; Xia Z; Cortopassi GA
Hum Mol Genet; 2015 May; 24(10):2848-60. PubMed ID: 25652399
[TBL] [Abstract][Full Text] [Related]
2. NDUFS4: creation of a mouse model mimicking a Complex I disorder.
Ingraham CA; Burwell LS; Skalska J; Brookes PS; Howell RL; Sheu SS; Pinkert CA
Mitochondrion; 2009 Jun; 9(3):204-10. PubMed ID: 19460290
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein 1 Overexpression Does Not Protect Against Mitochondrial Disease Pathology in Ndufs4 Knockout Mice.
Miller HC; Louw R; Mereis M; Venter G; Boshoff JD; Mienie L; van Reenen M; Venter M; Lindeque JZ; Domínguez-Martínez A; Quintana A; van der Westhuizen FH
Mol Neurobiol; 2021 Jan; 58(1):243-262. PubMed ID: 32918239
[TBL] [Abstract][Full Text] [Related]
4. Elevated susceptibility to exogenous seizure triggers and impaired interneuron excitability in a mouse model of Leigh syndrome epilepsy.
Manning A; Han V; Stephens A; Wang R; Bush N; Bard M; Ramirez JM; Kalume F
Neurobiol Dis; 2023 Oct; 187():106288. PubMed ID: 37704057
[TBL] [Abstract][Full Text] [Related]
5. The NDUFS4 Knockout Mouse: A Dual Threat Model of Childhood Mitochondrial Disease and Normative Aging.
Grillo AS; Bitto A; Kaeberlein M
Methods Mol Biol; 2021; 2277():143-155. PubMed ID: 34080150
[TBL] [Abstract][Full Text] [Related]
6. Ndufs4 KO mice: A model to study comorbid mood disorders associated with mitochondrial dysfunction.
van Rensburg DJ; Lindeque Z; Harvey BH; Steyn SF
Pharmacol Biochem Behav; 2024 Jan; 234():173689. PubMed ID: 38070656
[TBL] [Abstract][Full Text] [Related]
7. Ndufs4 ablation decreases synaptophysin expression in hippocampus.
Shil SK; Kagawa Y; Umaru BA; Nanto-Hara F; Miyazaki H; Yamamoto Y; Kobayashi S; Suzuki C; Abe T; Owada Y
Sci Rep; 2021 May; 11(1):10969. PubMed ID: 34040028
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease.
de Haas R; Das D; Garanto A; Renkema HG; Greupink R; van den Broek P; Pertijs J; Collin RWJ; Willems P; Beyrath J; Heerschap A; Russel FG; Smeitink JA
Sci Rep; 2017 Sep; 7(1):11733. PubMed ID: 28916769
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity.
Jin LW; Horiuchi M; Wulff H; Liu XB; Cortopassi GA; Erickson JD; Maezawa I
J Neurosci; 2015 Feb; 35(6):2516-29. PubMed ID: 25673846
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle mitochondria of NDUFS4-/- mice display normal maximal pyruvate oxidation and ATP production.
Alam MT; Manjeri GR; Rodenburg RJ; Smeitink JA; Notebaart RA; Huynen M; Willems PH; Koopman WJ
Biochim Biophys Acta; 2015; 1847(6-7):526-33. PubMed ID: 25687896
[TBL] [Abstract][Full Text] [Related]
11. Bipolar cell reduction precedes retinal ganglion neuron loss in a complex 1 knockout mouse model.
Song L; Yu A; Murray K; Cortopassi G
Brain Res; 2017 Feb; 1657():232-244. PubMed ID: 28027875
[TBL] [Abstract][Full Text] [Related]
12. MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function.
Caicedo A; Fritz V; Brondello JM; Ayala M; Dennemont I; Abdellaoui N; de Fraipont F; Moisan A; Prouteau CA; Boukhaddaoui H; Jorgensen C; Vignais ML
Sci Rep; 2015 Mar; 5():9073. PubMed ID: 25766410
[TBL] [Abstract][Full Text] [Related]
13. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid trafficking in starved cells: regulation by lipid droplet lipolysis, autophagy, and mitochondrial fusion dynamics.
Rambold AS; Cohen S; Lippincott-Schwartz J
Dev Cell; 2015 Mar; 32(6):678-92. PubMed ID: 25752962
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial control by DRP1 in brain tumor initiating cells.
Xie Q; Wu Q; Horbinski CM; Flavahan WA; Yang K; Zhou W; Dombrowski SM; Huang Z; Fang X; Shi Y; Ferguson AN; Kashatus DF; Bao S; Rich JN
Nat Neurosci; 2015 Apr; 18(4):501-10. PubMed ID: 25730670
[TBL] [Abstract][Full Text] [Related]
16. Region-Specific Defects of Respiratory Capacities in the Ndufs4(KO) Mouse Brain.
Kayser EB; Sedensky MM; Morgan PG
PLoS One; 2016; 11(1):e0148219. PubMed ID: 26824698
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice.
Johnson SC; Yanos ME; Bitto A; Castanza A; Gagnidze A; Gonzalez B; Gupta K; Hui J; Jarvie C; Johnson BM; Letexier N; McCanta L; Sangesland M; Tamis O; Uhde L; Van Den Ende A; Rabinovitch PS; Suh Y; Kaeberlein M
Front Genet; 2015; 6():247. PubMed ID: 26257774
[TBL] [Abstract][Full Text] [Related]
18. Opa1 overexpression ameliorates the phenotype of two mitochondrial disease mouse models.
Civiletto G; Varanita T; Cerutti R; Gorletta T; Barbaro S; Marchet S; Lamperti C; Viscomi C; Scorrano L; Zeviani M
Cell Metab; 2015 Jun; 21(6):845-54. PubMed ID: 26039449
[TBL] [Abstract][Full Text] [Related]
19. Key glycolytic enzyme activities of skeletal muscle are decreased under fed and fasted states in mice with knocked down levels of Shc proteins.
Hagopian K; Tomilov AA; Kim K; Cortopassi GA; Ramsey JJ
PLoS One; 2015; 10(4):e0124204. PubMed ID: 25880638
[TBL] [Abstract][Full Text] [Related]
20. In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics.
Nalbandian A; Llewellyn KJ; Gomez A; Walker N; Su H; Dunnigan A; Chwa M; Vesa J; Kenney MC; Kimonis VE
Mitochondrion; 2015 May; 22():1-8. PubMed ID: 25724235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
